Oral presentation

[1D10-13] Medical RI Production 1

Wed. Mar 16, 2022 2:45 PM - 3:50 PM Room D

Chair: Keita Nakano (JAEA)

2:45 PM - 3:00 PM

[1D10] Medical RI production using domestic nuclear infrastructures for self-sustenance

(1)Overall scope and plan

*Naoyuki Takaki¹, Yumi Kawata², Anri Inaki³, Kazuta Kobayashi⁴, Shigetaka Maeda⁵ (1. Tokyo City University, 2. NucMed, 3. Kanazawa University, 4. Mitsubishi Heavy Industry, 5. Japan Atomic Energy Agency)

3:00 PM - 3:15 PM

[1D11] Medical RI production using domestic nuclear infrastructures for self-sustenance

(2)Japan market size estimation on Ac225 radiopharmaceuticals

*Yumi Kawata¹, Takeo Morooka¹, Sunao Fujioka¹, Naoyuki Takaki² (1. Japan Medical Isotope K.K., 2. TOKYO CITY UNIVERSITY )

3:15 PM - 3:30 PM

[1D12] Medical RI production using domestic nuclear infrastructures for self-sustenance

(3)Concept study of Mo/Tc production using PWR power plant

*Shizuka Takahashi¹, Takashi Nakahara¹, Shinichi Tsuburaya¹, Kazuta Kobayashi¹, Takuya Nasu¹, Naoyuki TAKAKI² (1. MHI, 2. TCU)

3:30 PM - 3:45 PM

[1D13] Medical RI production using domestic nuclear infrastructures for self-sustenance

(4)Experimental consideration of ⁹⁹Mo / ^99mTc production process

*Kaori Nishikata¹, Yoshitaka Fujita¹, Misaki Seki¹, Tomoaki Takeuchi¹, Hiroshi Ide¹, Kunihiko Tsuchiya¹, Naoyuki Takaki² (1. JAEA, 2. TCU)

Time reserved for Chair （3:45 PM - 3:50 PM）

Oral presentation

[1D14-16] Medical RI Production 2

Wed. Mar 16, 2022 3:50 PM - 4:40 PM Room D

Chair: Sin-Ya Hohara (Kindai Univ.)

3:50 PM - 4:05 PM

[1D14] Medical RI production using domestic nuclear infrastructures for self-sustenance

(5)Ac-225 production using the experimental fast reactor Joyo

*Aru Sano¹, Shigetaka Maeda¹, wataru itagaki¹, Shinji Sasaki¹, Yoto Yuto², Naoyuki Takaki² (1. JAEA, 2. TCA)

4:05 PM - 4:20 PM

[1D15] Medical RI production using domestic nuclear infrastructures for self-sustenance

(6)Study of Ra/Ac separation method in Ac-225 production using fast reactor

Kazuki Ouchi¹, *Yoshihiro Kitatsuji¹, Shigetaka Maeda¹, Naoyuki Takaki² (1. JAEA, 2. TCU)

4:20 PM - 4:35 PM

[1D16] Medical RI production using domestic nuclear infrastructures for self-sustenance

(7)Ac-225 production using commercial PWR

*Yuto Sasaki¹, Naoyuki Takaki¹ (1. Tokyo City University )

Time reserved for Chair （4:35 PM - 4:40 PM）

Oral presentation

[1D17-19] Medical RI Production 3

Wed. Mar 16, 2022 4:40 PM - 5:30 PM Room D

Chair: Akito Oizumi (JAEA)

4:40 PM - 4:55 PM

[1D17] Evaluation of Ac-225 production by reduced moderation water reactor using light water or heavy water as coolants

*Tatsuya Fukumoto¹, Naoyuki Takaki¹ (1. Tokyo City University)

4:55 PM - 5:10 PM

[1D18] ²³⁰ThO₂ target irradiation behavior and optimization of irradiation conditions during Ac-225 production by PWR

*Tomofumi Yoneda¹, Yuto Sasaki¹, Naoyuki Takaki¹ (1. Tokyo City University)

5:10 PM - 5:25 PM

[1D19] Transport of fission products during a failure-of-capsule sealing accident in NSRR

*Yuiko Motome¹, Toru Nakatsuka¹, Masaki Amaya¹, Taisuke Yonomoto¹ (1. Japan Atomic Energy Agency)

Time reserved for Chair （5:25 PM - 5:30 PM）

Sessions

III. Fission Energy Engineering » 301-3 Research Reactor, Application of Neutron

[1D10-13] Medical RI Production 1

[1D10] Medical RI production using domestic nuclear infrastructures for self-sustenance

(1)Overall scope and plan

[1D11] Medical RI production using domestic nuclear infrastructures for self-sustenance

(2)Japan market size estimation on Ac225 radiopharmaceuticals

[1D12] Medical RI production using domestic nuclear infrastructures for self-sustenance

(3)Concept study of Mo/Tc production using PWR power plant

[1D13] Medical RI production using domestic nuclear infrastructures for self-sustenance

(4)Experimental consideration of ⁹⁹Mo / ^99mTc production process

[1D14-16] Medical RI Production 2

[1D14] Medical RI production using domestic nuclear infrastructures for self-sustenance

(5)Ac-225 production using the experimental fast reactor Joyo

[1D15] Medical RI production using domestic nuclear infrastructures for self-sustenance

(6)Study of Ra/Ac separation method in Ac-225 production using fast reactor

[1D16] Medical RI production using domestic nuclear infrastructures for self-sustenance

(7)Ac-225 production using commercial PWR

[1D17-19] Medical RI Production 3

[1D17] Evaluation of Ac-225 production by reduced moderation water reactor using light water or heavy water as coolants

[1D18] ²³⁰ThO₂ target irradiation behavior and optimization of irradiation conditions during Ac-225 production by PWR

[1D19] Transport of fission products during a failure-of-capsule sealing accident in NSRR

Authentication

Sessions

III. Fission Energy Engineering » 301-3 Research Reactor, Application of Neutron

[1D10-13] Medical RI Production 1

(1)Overall scope and plan

(2)Japan market size estimation on Ac225 radiopharmaceuticals

(3)Concept study of Mo/Tc production using PWR power plant

(4)Experimental consideration of 99Mo / 99mTc production process

[1D14-16] Medical RI Production 2

(5)Ac-225 production using the experimental fast reactor Joyo

(6)Study of Ra/Ac separation method in Ac-225 production using fast reactor

(7)Ac-225 production using commercial PWR

[1D17-19] Medical RI Production 3

Authentication

(4)Experimental consideration of ⁹⁹Mo / ^99mTc production process